John E. Kao
Chief Executive Officer, Director · Alignment Healthcare, Inc.
- 2024
- Sep 16, 2026
- 27
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies John E. Kao files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Dawn Christine Maroney - $9.99M in ALHC purchases and sales in the last 12 months
- Joseph S. Konowiecki - $3.46M in ALHC purchases and sales in the last 12 months
- Hyong Kim - $1.31M in ALHC purchases and sales in the last 12 months
- Andreas P. Wagner - $1.27M in ALHC purchases and sales in the last 12 months
- Christopher J. Joyce - $769K in ALHC purchases and sales in the last 12 months
- Sebastian Burzacchi - $274K in ALHC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John E. Kao?
John E. Kao is a corporate insider, tracked as Chief Executive Officer, Director of Alignment Healthcare, Inc. (ALHC). InsiderAlpha holds 27 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John E. Kao submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has John E. Kao been buying or selling stock?
Recorded transactions: 0 open-market purchases and 35 open-market sales ($80.11M) across all tracked filings.
